The renin angiotensin system regulates Kupffer cells in colorectal liver metastases

Cancer Biology and Therapy

Volumn 14, Issue 8, 2013, Pages 720-727

  Wen, Shu Wen ^a,b   Ager, Eleanor I ^a,c   Neo, Jaclyn ^a,d   Christophi, Christopher ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

Author keywords

ACE inhibitor; Captopril; Colorectal cancer; Kupffer cell; Macrophage

Indexed keywords

ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN[1-7]; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; GADOLINIUM CHLORIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER GROWTH; CARCINOGENESIS; CELL COUNT; CELL INVASION; COLORECTAL CANCER; COLORECTAL LIVER METASTASIS; CONTROLLED STUDY; DRUG EFFICACY; DRUG MECHANISM; IN VITRO STUDY; KUPFFER CELL; LIVER; MACROPHAGE; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; STEREOLOGY; TUMOR XENOGRAFT;

ACE INHIBITOR; CAPTOPRIL; COLORECTAL CANCER; KUPFFER CELL; MACROPHAGE;

ANGIOTENSIN I; ANGIOTENSIN II; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; CAPTOPRIL; COLORECTAL NEOPLASMS; DISEASE MODELS, ANIMAL; GADOLINIUM; KUPFFER CELLS; LIVER NEOPLASMS; MACROPHAGES; MALE; MICE; MICE, INBRED CBA; PEPTIDE FRAGMENTS; RENIN-ANGIOTENSIN SYSTEM;

EID: 84881461777     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.25092     Document Type: Article

References (62)

1. Ager EI, Neo J, Christophi C. The renin-angiotensin system and malignancy. Carcinogenesis 2008; 29:1675-84; PMID:18632755; http://dx.doi.org/ 10.1093/carcin/bgn171
2. De Paepe B, Verstraeten VL, De Potter CR, Vakaet LA, Bullock GR. Growth stimulatory angiotensin II type-1 receptor is upregulated in breast hyperplasia and in situ carcinoma but not in invasive carcinoma. Histochem Cell Biol 2001; 116:247-54; PMID:11685554
3. Rhodes DR, Ateeq B, Cao Q, Tomlins SA, Mehra R, Laxman B, et al. AGTR1 overexpression defines a subset of breast cancer and confers sensitivity to losartan, an AGTR1 antagonist. Proc Natl Acad Sci U S A 2009; 106:10284-9; PMID:19487683; http://dx.doi. org/10.1073/pnas.0900351106
4. Suganuma T, Ino K, Shibata K, Kajiyama H, Nagasaka T, Mizutani S, et al. Functional expression of the angiotensin II type 1 receptor in human ovarian carcinoma cells and its blockade therapy resulting in suppression of tumor invasion, angiogenesis, and peritoneal dissemination. Clin Cancer Res 2005; 11:2686-94; PMID:15814650; http://dx.doi.org/10.1158/1078-0432.CCR-04-1946
5. Uemura H, Hasumi H, Ishiguro H, Teranishi J, Miyoshi Y, Kubota Y. Renin-angiotensin system is an important factor in hormone refractory prostate cancer. Prostate 2006; 66:822-30; PMID:16482568; http://dx.doi.org/10.1002/pros. 20407
6. Gallagher PE, Tallant EA. Inhibition of human lung cancer cell growth by angiotensin-(1-7). Carcinogenesis 2004; 25:2045-52; PMID:15284177; http://dx.doi. org/10.1093/carcin/bgh236
7. Menon J, Soto-Pantoja DR, Callahan MF, Cline JM, Ferrario CM, Tallant EA, et al. Angiotensin-(1-7) inhibits growth of human lung adenocarcinoma xenografts in nude mice through a reduction in cyclooxygenase-2. Cancer Res 2007; 67:2809-15; PMID:17363603; http://dx.doi.org/10.1158/0008-5472.CAN-06-3614
8. Soto-Pantoja DR, Menon J, Gallagher PE, Tallant EA. Angiotensin-(1-7) inhibits tumor angiogenesis in human lung cancer xenografts with a reduction in vascular endothelial growth factor. Mol Cancer Ther 2009; 8:1676-83; PMID:19509262; http://dx.doi. org/10.1158/1535-7163.MCT-09-0161
9. Neo JH, Ager EI, Angus PW, Zhu J, Herath CB, Christophi C. Changes in the renin angiotensin system during the development of colorectal cancer liver metastases. BMC Cancer 2010; 10:134; PMID:20380732; http://dx.doi.org/10.1186/ 1471-2407-10-134
10. Neo JH, Malcontenti-Wilson C, Muralidharan V, Christophi C. Effect of ACE inhibitors and angiotensin II receptor antagonists in a mouse model of colorectal cancer liver metastases. J Gastroenterol Hepatol 2007; 22:577-84; PMID:17376054; http://dx.doi. org/10.1111/j.1440-1746.2006.04797.x
11. Leung PS, Suen PM, Ip SP, Yip CK, Chen G, Lai PB. Expression and localization of AT1 receptors in hepatic Kupffer cells: its potential role in regulating a fibrogenic response. Regul Pept 2003; 116:61-9; PMID:14599716; http://dx.doi.org/10.1016/S0167-0115(03)00192-7
12. Kolios G, Valatas V, Kouroumalis E. Role of Kupffer cells in the pathogenesis of liver disease. World J Gastroenterol 2006; 12:7413-20; PMID:17167827
13. van der Bij GJ, Oosterling SJ, Meijer S, Beelen RH, van Egmond M. Therapeutic potential of Kupffer cells in prevention of liver metastases outgrowth. Immunobiology 2005; 210:259-65; PMID:16164033; http://dx.doi.org/10. 1016/j.imbio.2005.05.020
14. Paschos KA, Majeed AW, Bird NC. Role of Kupffer cells in the outgrowth of colorectal cancer liver metastases. Hepatol Res 2010; 40:83-94; PMID:19788686; http://dx.doi.org/10.1111/j.1872-034X.2009.00578.x
15. Bilzer M, Roggel F, Gerbes AL. Role of Kupffer cells in host defense and liver disease. Liver Int 2006; 26:1175-86; PMID:17105582; http://dx.doi. org/10.1111/j.1478-3231.2006.01342.x
16. Egami K, Murohara T, Shimada T, Sasaki K, Shintani S, Sugaya T, et al. Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth. J Clin Invest 2003; 112:67-75; PMID:12840060
17. Lin C, Datta V, Okwan-Duodu D, Chen X, Fuchs S, Alsabeh R, et al. Angiotensin-converting enzyme is required for normal myelopoiesis. FASEB J 2011; 25:1145-55; PMID:21148418; http://dx.doi. org/10.1096/fj.10-169433
18. Fujimoto Y, Sasaki T, Tsuchida A, Chayama K. Angiotensin II type 1 receptor expression in human pancreatic cancer and growth inhibition by angiotensin II type 1 receptor antagonist. FEBS Lett 2001; 495:197-200; PMID:11334891; http://dx.doi. org/10.1016/S0014-5793(01)02377-8
19. Kikkawa F, Mizuno M, Shibata K, Kajiyama H, Morita T, Ino K, et al. Activation of invasiveness of cervical carcinoma cells by angiotensin II. Am J Obstet Gynecol 2004; 190:1258-63; PMID:15167827; http://dx.doi. org/10.1016/j.ajog.2003.12.013
20. Stoeltzing O, Liu W, Reinmuth N, Parikh A, Ahmad SA, Jung YD, et al. Angiogenesis and antiangiogenic therapy of colon cancer liver metastasis. Ann Surg Oncol 2003; 10:722-33; PMID:12900362; http://dx.doi.org/10.1245/ASO.2003. 07.019
21. Uemura H, Ishiguro H, Nakaigawa N, Nagashima Y, Miyoshi Y, Fujinami K, et al. Angiotensin II receptor blocker shows antiproliferative activity in prostate cancer cells: a possibility of tyrosine kinase inhibitor of growth factor. Mol Cancer Ther 2003; 2:1139-47; PMID:14617787
22. Danilov SM, Sadovnikova E, Scharenborg N, Balyasnikova IV, Svinareva DA, Semikina EL, et al. Angiotensin-converting enzyme (CD143) is abundantly expressed by dendritic cells and discriminates human monocyte-derived dendritic cells from acute myeloid leukemia-derived dendritic cells. Exp Hematol 2003; 31:1301-9; PMID:14662338; http://dx.doi. org/10.1016/j.exphem.2003.08.018
23. Geara AS, Azzi J, Jurewicz M, Abdi R. The reninangiotensin system: an old, newly discovered player in immunoregulation. Transplant Rev (Orlando) 2009; 23:151-8; PMID:19539879; http://dx.doi. org/10.1016/j.trre.2009.04.002
24. Ruiz-Ortega M, Bustos C, Hernández-Presa MA, Lorenzo O, Plaza JJ, Egido J. Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factorkappa B activation and monocyte chemoattractant protein-1 synthesis. J Immunol 1998; 161:430-9; PMID:9647253
25. Abd Alla J, Langer A, Elzahwy SS, Arman-Kalcek G, Streichert T, Quitterer U. Angiotensin-converting enzyme inhibition down-regulates the pro-atherogenic chemokine receptor 9 (CCR9)-chemokine ligand 25 (CCL25) axis. J Biol Chem 2010; 285:23496-505; PMID:20504763; http://dx.doi.org/10.1074/jbc. M110.117481
26. Clozel M, Kuhn H, Hefti F, Baumgartner HR. Endothelial dysfunction and subendothelial monocyte macrophages in hypertension. Effect of angiotensin converting enzyme inhibition. Hypertension 1991; 18:132-41; PMID:1653185; http://dx.doi. org/10.1161/01.HYP.18.2.132
27. Hernández-Presa M, Bustos C, Ortego M, Tuñon J, Renedo G, Ruiz-Ortega M, et al. Angiotensinconverting enzyme inhibition prevents arterial nuclear factor-kappa B activation, monocyte chemoattractant protein-1 expression, and macrophage infiltration in a rabbit model of early accelerated atherosclerosis. Circulation 1997; 95:1532-41; PMID:9118522; http://dx.doi.org/10.1161/01.CIR.95.6.1532
28. Kowala MC, Grove RI, Aberg G. Inhibitors of angiotensin converting enzyme decrease early atherosclerosis in hyperlipidemic hamsters. Fosinopril reduces plasma cholesterol and captopril inhibits macrophage-foam cell accumulation independently of blood pressure and plasma lipids. Atherosclerosis 1994; 108:61-72; PMID:7980708; http://dx.doi.org/10.1016/0021-9150(94)90037-X
29. Ozawa Y, Kobori H, Suzaki Y, Navar LG. Sustained renal interstitial macrophage infiltration following chronic angiotensin II infusions. Am J Physiol Renal Physiol 2007; 292:F330-9; PMID:16804106; http://dx.doi.org/10.1152/ ajprenal.00059.2006
30. Wenzel UO, Thaiss F, Helmchen U, Stahl RA, Wolf G. Angiotensin II infusion ameliorates the early phase of a mesangioproliferative glomerulonephritis. Kidney Int 2002; 61:1020-9; PMID:11849457; http://dx.doi. org/10.1046/j.1523-1755.2002.00192.x
31. Santos RA, Ferreira AJ. Angiotensin-(1-7) and the renin-angiotensin system. Curr Opin Nephrol Hypertens 2007; 16:122-8; PMID:17293687; http://dx.doi.org/10.1097/MNH.0b013e328031f362
32. Fujita M, Hayashi I, Yamashina S, Itoman M, Majima M. Blockade of angiotensin AT1a receptor signaling reduces tumor growth, angiogenesis, and metastasis. Biochem Biophys Res Commun 2002; 294:441-7; PMID:12051731; http://dx.doi.org/10.1016/S0006-291X(02)00496-5
33. Imai N, Hashimoto T, Kihara M, Yoshida S, Kawana I, Yazawa T, et al. Roles for host and tumor angiotensin II type 1 receptor in tumor growth and tumorassociated angiogenesis. Lab Invest 2007; 87:189-98; PMID:17318197; http://dx.doi.org/10.1038/labinvest. 3700504
34. Suzuki Y, Ruiz-Ortega M, Lorenzo O, Ruperez M, Esteban V, Egido J. Inflammation and angiotensin II. Int J Biochem Cell Biol 2003; 35:881-900; PMID:12676174; http://dx.doi.org/10.1016/S1357-2725(02)00271-6
35. Bumpus FM. Angiotensin I and II. Some early observations made at the Cleveland Clinic Foundation and recent discoveries relative to angiotensin II formation in human heart. Hypertension 1991; 18(Suppl):III122-5; PMID:1937674; http://dx.doi.org/10.1161/01. HYP.18.5-Suppl.III122
36. Lindpaintner K, Jin M, Wilhelm MJ, Suzuki F, Linz W, Schoelkens BA, et al. Intracardiac generation of angiotensin and its physiologic role. Circulation 1988; 77:I18-23; PMID:3286043
37. Heuff G, Oldenburg HS, Boutkan H, Visser JJ, Beelen RH, Van Rooijen N, et al. Enhanced tumour growth in the rat liver after selective elimination of Kupffer cells. Cancer Immunol Immunother 1993; 37:125-30; PMID:8319242; http://dx.doi.org/10.1007/BF01517045
38. Pearson HJ, Anderson J, Chamberlain J, Bell PR. The effect of Kupffer cell stimulation or depression on the development of liver metastases in the rat. Cancer Immunol Immunother 1986; 23:214-6; PMID:3024833; http://dx.doi.org/10.1007/BF00205652
39. Rushfeldt C, Sveinbjørnsson B, Seljelid R, Smedsrød B. Early events of hepatic metastasis formation in mice: role of Kupffer and NK-cells in natural and interferongamma-stimulated defense. J Surg Res 1999; 82:209-15; PMID:10090831; http://dx.doi.org/10.1006/jsre.1998.5532
40. Timmers M, Vekemans K, Vermijlen D, Asosingh K, Kuppen P, Bouwens L, et al. Interactions between rat colon carcinoma cells and Kupffer cells during the onset of hepatic metastasis. Int J Cancer 2004; 112:793-802; PMID:15386374; http://dx.doi. org/10.1002/ijc.20481
41. Amirshahrokhi K, Ghazi-khansari M, Mohammadi-Farani A, Karimian G. Effect of captopril on TNF-α and IL-10 in the livers of bile duct ligated rats. Iran J Immunol 2010; 7:247-51; PMID:21189448
42. Attoub S, Gaben AM, Al-Salam S, Al Sultan MA, John A, Nicholls MG, et al. Captopril as a potential inhibitor of lung tumor growth and metastasis. Ann N Y Acad Sci 2008; 1138:65-72; PMID:18837885; http://dx.doi.org/10.1196/annals. 1414.011
43. Miguel-Carrasco JL, Zambrano S, Blanca AJ, Mate A, Vázquez CM. Captopril reduces cardiac inflammatory markers in spontaneously hypertensive rats by inactivation of NF-kB. J Inflamm (Lond) 2010; 7:21; PMID:20462420; http://dx.doi.org/10.1186/1476-9255-7-21
44. Volpert OV, Ward WF, Lingen MW, Chesler L, Solt DB, Johnson MD, et al. Captopril inhibits angiogenesis and slows the growth of experimental tumors in rats. J Clin Invest 1996; 98:671-9; PMID:8698858; http://dx.doi.org/10.1172/ JCI118838
45. Condeelis J, Pollard JW. Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 2006; 124:263-6; PMID:16439202; http://dx.doi.org/10.1016/j.cell.2006.01.007
46. Hamada I, Kato M, Yamasaki T, Iwabuchi K, Watanabe T, Yamada T, et al. Clinical effects of tumor-associated macrophages and dendritic cells on renal cell carcinoma. Anticancer Res 2002; 22(6C):4281-4; PMID:12553070
47. Hanada T, Nakagawa M, Emoto A, Nomura T, Nasu N, Nomura Y. Prognostic value of tumor-associated macrophage count in human bladder cancer. Int J Urol 2000; 7:263-9; PMID:10910229; http://dx.doi. org/10.1046/j.1442-2042.2000.00190. x
48. Knittel T, Mehde M, Kobold D, Saile B, Dinter C, Ramadori G. Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: regulation by TNF-alpha and TGF-beta1. J Hepatol 1999; 30:48-60; PMID:9927150; http://dx.doi.org/10.1016/S0168-8278(99) 80007-5
49. Leek RD, Landers RJ, Harris AL, Lewis CE. Necrosis correlates with high vascular density and focal macrophage infiltration in invasive carcinoma of the breast. Br J Cancer 1999; 79:991-5; PMID:10070902; http://dx.doi.org/10.1038/sj. bjc.6690158
50. Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer 2004; 4:71-8; PMID:14708027; http://dx.doi. org/10.1038/nrc1256
51. Nakamura T. Structure and function of hepatocyte growth factor. Prog Growth Factor Res 1991; 3:67-85; PMID:1838014; http://dx.doi.org/10.1016/0955- 2235(91)90014-U
52. Noji S, Tashiro K, Koyama E, Nohno T, Ohyama K, Taniguchi S, et al. Expression of hepatocyte growth factor gene in endothelial and Kupffer cells of damaged rat livers, as revealed by in situ hybridization. Biochem Biophys Res Commun 1990; 173:42-7; PMID:2147853; http://dx.doi.org/10.1016/S0006-291X(05) 81018-6
53. Koh SL, Ager E, Malcontenti-Wilson C, Muralidharan V, Christophi C. Blockade of the renin-angiotensin system improves the early stages of liver regeneration and liver function. J Surg Res 2013; 179:66-71; PMID:23110972; http://dx.doi.org/10.1016/j. jss.2012.09.007
54. Kuruppu D, Christophi C, Bertram JF, O'Brien PE. Characterization of an animal model of hepatic metastasis. J Gastroenterol Hepatol 1996; 11:26-32; PMID:8672738; http://dx.doi. org/10.1111/j.1440-1746.1996.tb00006.x
55. Ager EI, Wen SW, Chan J, Chong WW, Neo JH, Christophi C. Altered efficacy of AT1R-targeted treatment after spontaneous cancer cell-AT1R upregulation. BMC Cancer 2011; 11:274; PMID:21703011; http://dx.doi.org/10.1186/1471-2407-11-274
56. Hirano T, Ran J, Adachi M. Opposing actions of angiotensin II type 1 and 2 receptors on plasma cholesterol levels in rats. J Hypertens 2006; 24:103-8; PMID:16331107; http://dx.doi.org/10.1097/01. hjh.0000198030.30095.98
57. Zhang Y, Griendling KK, Dikalova A, Owens GK, Taylor WR. Vascular hypertrophy in angiotensin II-induced hypertension is mediated by vascular smooth muscle cell-derived H2O2. Hypertension 2005; 46:732-7; PMID:16172434; http://dx.doi. org/10.1161/01.HYP.0000182660.74266.6d
58. Hardonk MJ, Dijkhuis FW, Hulstaert CE, Koudstaal J. Heterogeneity of rat liver and spleen macrophages in gadolinium chloride-induced elimination and repopulation. J Leukoc Biol 1992; 52:296-302; PMID:1522388
59. Kono H, Fujii H, Asakawa M, Yamamoto M, Maki A, Matsuda M, et al. Functional heterogeneity of the kupffer cell population is involved in the mechanism of gadolinium chloride in rats administered endotoxin. J Surg Res 2002; 106:179-87; PMID:12127824; http://dx.doi.org/10.1006/jsre.2002.6434
60. Maher JM, Aleksunes LM, Dieter MZ, Tanaka Y, Peters JM, Manautou JE, et al. Nrf2-and PPAR alpha-mediated regulation of hepatic Mrp transporters after exposure to perfluorooctanoic acid and perfluorodecanoic acid. Toxicol Sci 2008; 106:319-28; PMID:18757529; http://dx.doi.org/10.1093/toxsci/kfn177
61. Mizgerd JP, Molina RM, Stearns RC, Brain JD, Warner AE. Gadolinium induces macrophage apoptosis. J Leukoc Biol 1996; 59:189-95; PMID:8603991
62. Ishizu K, Sunose N, Yamazaki K, Tsuruo T, Sadahiro S, Makuuchi H, et al. Development and characterization of a model of liver metastasis using human colon cancer HCT-116 cells. Biol Pharm Bull 2007; 30:1779-83; PMID:17827739; http://dx.doi.org/10.1248/bpb.30.1779